Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

New AI regulation in the EU seeks to reduce risk without assessing public benefit


The European Union’s new AI Act focuses on risk without considering benefits, which could hinder the development of new technology while failing to protect the public.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The AI Act tailors regulation to different levels of presumed risk.


  1. European Union. EUR-Lex (accessed 3 March 2024).

  2. European Parliament. (accessed 3 March 2024).

  3. Moës, N. & Ryan, F. The Future Society (2023).

  4. Laux, J., Wachter, S., & Mittelstadt, B. in Regulation & Governance Vol. 18 (eds. Levi-Faur, D. et al.) 3–32 (2024).

  5. European Commission. EUR-Lex (2021).

  6. Novelli, C., Casolari, F., Rotolo, A., Taddeo, M. & Floridi, L. AI Soc. (2023).

    Article  Google Scholar 

  7. Prainsack, B., El-Sayed, S., Forgó, N., Szoszkiewicz, Ł. & Baumer, P. Lancet Digit. Health 4, e773–e774 (2022).

    Article  CAS  PubMed  Google Scholar 

  8. El-Sayed, S. et al. PLUTO - Public Value Assessment Tool (2023).

  9. Pfotenhauer, S. M., Juhl, J. & Aarden, E. Res. Policy 48, 895–904 (2019).

    Article  Google Scholar 

  10. Birch, K., Chiappetta, M. & Artyushina, A. Policy Stud. 5, 468–487 (2020).

    Article  Google Scholar 

  11. Coad, A., Nightingale, P., Stilgoe, J. & Vezzani, A (eds.). The Dark Side of Innovation (Routledge, 2022).

  12. European Commission, Directorate-General for Research and Innovation, European Group on Ethics in Science and New Technologies. Publications Office of the European Union (2023).

  13. Expert Panel on the Socioeconomic Impacts of Science and Health Misinformation. CCA CIC (23 January 2023).

  14. McMahon, A., Buyx, A. & Prainsack, B. Med. Law Rev. 28, 155–182 (2019).

    Google Scholar 

  15. Jones, E. Ada Lovelace Institute (12 October 2023).

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Barbara Prainsack.

Ethics declarations

Competing interests

B.P. is a member of the Austrian National Bioethics Commission, and Chair of the European Group on Ethics in Science and New Technologies (EGE). N.F. is a member of the Austrian Data Protection Board and the AI Board, both independent consultancy bodies to the Austrian Government, and also serves as principal investigator in several European Union-funded research projects on AI (full list: This Comment was written in a personal academic capacity by both authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prainsack, B., Forgó, N. New AI regulation in the EU seeks to reduce risk without assessing public benefit. Nat Med 30, 1235–1237 (2024).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing